Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||22.31 M||Cash From Investing Activities||-310 K||Cash From Operating Activities||-8.47 M||Gross Profit|
|Net Profit||-16.62 M||Operating Profit||-7.28 M||Total Assets||138.76 M||Total Current Assets||136.96 M|
|Total Current Liabilities||40.72 M||Total Debt||1.1 M||Total Liabilities||51.05 M||Total Revenue||9.57 M|
|High 52 week||6.83||Low 52 week||0.96||Last close||1||Last change||1.21%|
|RSI||39.29||Average true range||0.08||Beta||1.32||Volume||206.2 K|
|Simple moving average 20 days||-5.61%||Simple moving average 50 days||-16.96%||Simple moving average 200 days||-60.26%|
|Performance Week||0.3%||Performance Month||-25.93%||Performance Quart||-31.97%||Performance Half||-72.9%|
|Performance Year||-83.55%||Performance Year-to-date||-62.12%||Volatility daily||3.1%||Volatility weekly||6.94%|
|Volatility monthly||14.22%||Volatility yearly||49.24%||Relative Volume||205.44%||Average Volume||439.51 K|
|New High||New Low|
2020-02-24 16:15:10 | Aduro Biotech to Present at the Cowen and Company 40th Annual Health Care Conference
2020-02-19 12:31:05 | Aduro Biotech ADRO Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-02-19 12:00:05 | Aduro Biotech ADRO Upgraded to Strong Buy: Here's Why
2020-02-19 08:15:10 | Aduro Biotech to Present at the 9th Annual SVB Leerink Global Healthcare Conference
2020-01-10 18:03:18 | East Bay cancer drug developer, jilted by Novartis, to cut 51 jobs
2020-01-10 18:00:38 | Biotechs punch up talking points leading into big Union Square conference
2020-01-09 16:15:10 | Aduro Biotech Announces Corporate Restructuring
2019-12-14 17:18:16 | Hedge Funds Are Betting On Aduro BioTech Inc ADRO
2019-12-09 05:06:57 | Does Aduro BioTech, Inc. NASDAQ:ADRO Have A Volatile Share Price?
2019-12-07 11:31:04 | Aduro Biotech ADRO Up 7.5% Since Last Earnings Report: Can It Continue?
2019-11-08 16:05:00 | Aduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th Annual Meeti
2019-11-08 12:20:05 | Aduro ADRO Q3 Loss Wider Than Expected, Revenues Rise Y/Y
2019-11-07 19:35:12 | Aduro Biotech ADRO Reports Q3 Loss, Tops Revenue Estimates
2019-11-07 16:05:00 | Aduro Biotech Provides Business Update and Reports Third Quarter 2019 Financial Results
2019-10-25 07:49:40 | Should You Worry About Aduro BioTech, Inc.'s NASDAQ:ADRO CEO Pay?
2019-09-30 16:05:00 | Aduro Biotech to Present at the 2019 Cantor Global Healthcare Conference
2019-09-19 09:49:55 | Do Insiders Own Lots Of Shares In Aduro BioTech, Inc. NASDAQ:ADRO?
2019-09-04 08:30:00 | Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 MIW815 in Combination with KEYTRUDA® pembrolizumab for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma HNSCC
2019-09-03 16:05:00 | Aduro Biotech to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-08-31 09:31:01 | Why Is Aduro Biotech ADRO Down 12.1% Since Last Earnings Report?
2019-08-14 14:32:40 | Who Has Been Selling Aduro BioTech, Inc. NASDAQ:ADRO Shares?
2019-08-05 10:46:02 | Aduro ADRO Earnings Miss in Q2, Revenues Meet Estimates
2019-08-01 16:05:00 | Aduro Biotech Provides Business Update and Reports Second Quarter 2019 Financial Results
2019-07-31 10:36:02 | Aduro Biotech ADRO May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2019-07-16 11:04:03 | AbbVie ABBV Acquires Mavupharma to Boost Cancer Portfolio
2019-06-04 10:32:02 | Aduro Stock Crashes After ASCO Updates on Cancer Candidate
2019-06-02 11:45:00 | Aduro Biotech and Novartis Present Results from Ongoing Phase 1b Study of STING Agonist ADU-S100 MIW815 in Combination with Anti-PD-1 Monoclonal Antibody Spartalizumab PDR001 in Patients with Advanced Solid Tumors or Lymphomas
2019-05-15 17:05:00 | Aduro Biotech Announces Clinical Program Update for Anti-APRIL Antibody BION-1301
2019-05-08 12:06:04 | Aduro ADRO Q1 Earnings and Revenues Fall Shy of Estimates
2019-05-07 18:45:10 | Aduro Biotech ADRO Reports Q1 Loss, Misses Revenue Estimates
2019-05-07 16:54:08 | What's in Store for Axsome AXSM This Earnings Season?
2019-05-07 16:05:00 | Aduro Biotech Reports First Quarter 2019 Financial Results
2019-05-07 10:53:02 | Guardant Health GH to Report Q1 Earnings: What's in Store?
2019-05-07 10:47:02 | Proteostasis PTI to Post Q1 Earnings: What's in Store?
2019-05-06 16:13:08 | Soleno Therapeutics SLNO to Post Q1 Earnings: What's Up?
2019-05-06 15:06:07 | What's in the Cards for Perrigo PRGO This Earnings Season?
2019-05-06 11:54:03 | Assertio Therapeutics ASRT to Post Q1 Earnings: What's Up?
2019-05-03 17:22:09 | Mylan MYL to Report Q1 Earnings: What's in the Offing?
2019-05-03 10:32:02 | What's in Store for Sorrento SRNE This Earnings Season?
2019-05-02 10:58:02 | PDL BioPharma PDLI to Post Q1 Earnings: What's in Store?
2019-05-01 18:07:10 | Is a Beat in the Cards for Mallinckrodt MNK Q1 Earnings?
2019-04-30 11:39:03 | AVEO Pharmaceuticals AVEO to Post Q1 Earnings: What's Up?
2019-04-30 09:15:01 | Small Gains Still Bring New Highs
2019-04-30 08:16:12 | What's in the Cards for Bausch Health BHC Q1 Earnings?
2019-04-29 18:14:10 | Is a Beat in the Cards for Incyte INCY in Q1 Earnings?
2019-04-28 23:52:03 | Sangamo SGMO Q1 Earnings: What's in Store for the Stock?